Lung Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Lung Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-03-21Clinical Trial Update: A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System
A Mayo Clinic trial update on isolating and testing circulating tumor cells using the ClearCell FX EP+ System in lung cancer; the study stat…
-
CLINICAL_TRIALS trial_result · 2017-12-18Clinical Trial Update: Study of Apatinib as the Maintenance Therapy in Advanced Lung Adenocarcinoma [Phase 2]
Phase 2 study evaluating apatinib as maintenance therapy in advanced lung adenocarcinoma; status not specified in the provided snippet.
-
CLINICAL_TRIALS trial_result · 2017-07-28Clinical Trial Update: AVAdeno Study: An Observational Study of First-Line Avastin (Bevacizumab) in Patients With Adenocarcinoma of the Lung
An observational study evaluating first-line bevacizumab (Avastin) in patients with lung adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: A Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-Small Cell Lung Adenocarcinoma [Phase 1]
This Phase I trial investigates SS1 (dsFv) PE38 combined with paclitaxel, carboplatin, and bevacizumab in patients with unresectable non-sma…
-
CLINICAL_TRIALS research · 2017-03-27Clinical Trial Update: Circulating Tumor DNA (ctDNA) as a Prognostic Tool in Patients With Advanced Lung Adenocarcinoma
This clinical trial update describes evaluating circulating tumor DNA (ctDNA) as a prognostic biomarker in patients with advanced lung adeno…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-03-03Clinical Trial Update: ALK Rearrangements in Lung Adenocarcinoma: Epidemiology in Latin America (CLICaP)
Clinical trial update analyzing ALK rearrangements in lung adenocarcinoma; focusing on epidemiology in Latin America.
-
CLINICAL_TRIALS research · 2017-02-24Clinical Trial Update: Blood Detection of EGFR Mutation For Iressa Treatment [NA]
This clinical trial update covers blood-based detection of EGFR mutations to guide Iressa (gefitinib) therapy in lung adenocarcinoma. The tr…
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma [Phase 4]
A Phase 4 trial update on icotinib as first-line and maintenance therapy for patients with EGFR-mutated non-small cell lung cancer (lung ade…
-
CLINICAL_TRIALS research · 2017-01-24Clinical Trial Update: Detection of CSF Next Generation Sequencing in the Application of Brain Metastases From Lung Adenocarcinoma or Meningeal Metastasis
A clinical trial sponsored by Shandong Cancer Hospital and Institute is evaluating cerebrospinal fluid next-generation sequencing for detect…
-
CLINICAL_TRIALS trial_result · 2016-11-29Clinical Trial Update: EGFRdelEx19 and KRAS Exon 2 Mutation Detection in EBUS-TBNA
A completed clinical trial update reports on detecting EGFR delEx19 and KRAS exon 2 mutations in EBUS-TBNA samples from patients with metast…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: Application of Detecting Circulating Tumor Cells in the Accurate Treatment of Early Stage Lung Adenocarcinoma [NA]
This clinical trial update discusses applying circulating tumor cell detection to tailor treatment in patients with early-stage lung adenoca…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A+C in Metastatic Lung Adenocarcinoma Cancer [Phase 2]
Phase 2 clinical trial update on a combination therapy for metastatic lung adenocarcinoma. The current status is listed as UNKNOWN in the pr…
-
CLINICAL_TRIALS research · 2016-11-01Clinical Trial Update: Chemotherapy Plus Gefitinib for Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomized Controlled Trial [Phase 2]
A Phase 2 randomized trial evaluating whether adding gefitinib to chemotherapy improves outcomes in advanced lung adenocarcinoma with sensit…
-
CLINICAL_TRIALS trial_result · 2016-09-30Clinical Trial Update: Metformin in Stage IV Lung Adenocarcinoma [Phase 2]
A Phase 2 trial of metformin in stage IV non-small cell lung cancer (lung adenocarcinoma) has been terminated.
-
CLINICAL_TRIALS research · 2016-09-13Clinical Trial Update: Chemoresistance and Involvement of the NOTCH Pathway in Patients With Lung Adenocarcinoma
This clinical trial update discusses chemoresistance and involvement of the NOTCH signaling pathway in patients with lung adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2016-09-08Clinical Trial Update: Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating paclitaxel, carboplatin, and bevacizumab with or without Cixutumumab in stage IV or recurrent non-small cell lung c…
-
CLINICAL_TRIALS trial_result · 2016-08-16Clinical Trial Update: Safety and Pharmacology Study of SNX-5422 in Subjects With Resistant Lung Adenocarcinoma [Phase 1]
This is a completed Phase 1 safety and pharmacology study of SNX-5422 in subjects with resistant lung adenocarcinoma.
-
CLINICAL_TRIALS research · 2016-07-26Clinical Trial Update: Molecular Analysis of 150 Lung Adenocarcinoma
Clinical trial update describing molecular analysis of 150 lung adenocarcinoma samples.
-
CLINICAL_TRIALS research · 2016-06-21Clinical Trial Update: Endostar Durative Transfusion Combined With Chemotherapy in the Treatment of Advanced Lung Adenocarcinoma [Phase 4]
A Phase 4 clinical trial update describing Endostar (recombinant human endostatin) given with chemotherapy for advanced lung adenocarcinoma;…
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: Pilot and Feasibility Study of the Imaging Potential of EC17: Intraoperative Folate-fluorescein Conjugate (EC17) Lung Cancer (CA) [Phase 1]
Phase 1 trial update evaluating EC17, a folate-fluorescein imaging agent, for intraoperative visualization of lung cancer; the study has com…
-
CLINICAL_TRIALS research · 2016-04-14Clinical Trial Update: A Study to Predict Gefitinib' s Efficacy for Lung Cancer by Plasma Free Nucleic Acids EGFR Gene Mutation Test
Study exploring whether plasma free nucleic acids EGFR mutation testing can predict gefitinib efficacy in lung adenocarcinoma.
-
CLINICAL_TRIALS research · 2016-03-10Clinical Trial Update: Tarceva With or Without Apatinib in the Advanced Lung Adenocarcinoma [Phase 2]
Phase 2 clinical trial evaluating erlotinib (Tarceva) with or without apatinib in advanced lung adenocarcinoma. The status of the trial is n…
-
CLINICAL_TRIALS trial_result · 2016-03-01Clinical Trial Update: NOV120101 (Poziotinib) for 1st Line Monotherapy in Patients With Lung Adenocarcinoma [Phase 2]
A Phase 2 study of poziotinib as first-line monotherapy for lung adenocarcinoma (Stage IIIB/Stage IV) was terminated; the update does not re…
-
CLINICAL_TRIALS other · 2016-02-25Clinical Trial Update: Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Lung Adenocarcinoma Harboring Wild-type EGFR [Phase 1]
Phase 1 trial evaluating apatinib plus docetaxel as second-line treatment for advanced lung adenocarcinoma with wild-type EGFR; status is un…
-
CLINICAL_TRIALS research · 2016-02-05Clinical Trial Update: The Study of Apatinib Plus CIK as the Third Line Therapy for Advanced Lung Adenocarcinoma Patients With Wild-Type EGFR [Phase 2]
Phase 2 clinical trial evaluating apatinib plus cytokine-induced killer (CIK) cells as third-line therapy for advanced lung adenocarcinoma.